Pharmaceutical Technology9 日
REC-01 by Purec for Hypophosphatasia: Likelihood of Approval
REC-01 is under development for the treatment of hypophosphatasia. The therapeutic candidate comprises purified mesenchymal stem cells. Purec is a provider of stem cell therapy solution. Purec is ...